Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average‐risk medulloblastoma: COG A9961

Assess the intellectual and academic outcomes as well as risk factors associated with treatment for average‐risk medulloblastoma in childhood using 23.4 Gy of craniospinal radiotherapy plus adjuvant chemotherapy.

[1]  P. S. Achilles.  THE PSYCHOLOGICAL CORPORATION. , 1923, Science.

[2]  P. Robertson,et al.  Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. , 2006, Journal of neurosurgery.

[3]  M. Noseworthy,et al.  Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ. , 2006, Neuro-oncology.

[4]  K. Ligon,et al.  Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies , 2007, Annals of neurology.

[5]  Bruce Gordon,et al.  Test Review: Wechsler, D. (2002). The Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III). San Antonio, TX: The Psychological Corporation , 2004 .

[6]  Elizabeth M. Wells,et al.  Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin. , 2010, Journal of neurosurgery. Pediatrics.

[7]  F. Berthold,et al.  Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. , 2009, Neuro-oncology.

[8]  P. Huh,et al.  Coexisting intracranial meningeal melanocytoma, dermoid tumor, and Dandy-Walker cyst in a patient with neurocutaneous melanosis. Case report. , 2006, Journal of neurosurgery.

[9]  C. Sainte-Rose,et al.  Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. , 2004, Journal of neurosurgery.

[10]  W E Reddick,et al.  Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  W. Reddick,et al.  Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. , 2003, Neuropsychology.

[12]  D. Figarella-Branger,et al.  Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Packer,et al.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Y. Stern.  What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.

[15]  Eric Bouffet,et al.  Change in neurocognitive functioning after treatment with cranial radiation in childhood. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. J. van der Kogel,et al.  Mechanisms of radiation injury to the central nervous system: implications for neuroprotection. , 2004, Molecular interventions.

[17]  J L Kepner,et al.  Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Burger,et al.  Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Douglas C. Miller,et al.  Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Uwe Oelfke,et al.  Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function , 2008, Pediatric blood & cancer.

[21]  R. Mulhern,et al.  Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.